Growth Metrics

Quest Diagnostics (DGX) Acquisitions (2016 - 2026)

Quest Diagnostics' Acquisitions history spans 17 years, with the latest figure at $38.0 million for Q1 2026.

  • On a quarterly basis, Acquisitions changed N/A to $38.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $139.0 million, a 77.97% decrease, with the full-year FY2025 number at $101.0 million, down 95.33% from a year prior.
  • Acquisitions hit $38.0 million in Q1 2026 for Quest Diagnostics, down from $50.0 million in the prior quarter.
  • Over the last five years, Acquisitions for DGX hit a ceiling of $578.0 million in Q2 2023 and a floor of $1.0 million in Q2 2022.
  • Historically, Acquisitions has averaged $130.4 million across 5 years, with a median of $44.0 million in 2022.
  • Biggest five-year swings in Acquisitions: tumbled 99.57% in 2022 and later surged 57700.0% in 2023.
  • Tracing DGX's Acquisitions over 5 years: stood at $38.0 million in 2022, then plummeted by 94.74% to $2.0 million in 2023, then soared by 19050.0% to $383.0 million in 2024, then plummeted by 86.95% to $50.0 million in 2025, then fell by 24.0% to $38.0 million in 2026.
  • Business Quant data shows Acquisitions for DGX at $38.0 million in Q1 2026, $50.0 million in Q4 2025, and $34.0 million in Q3 2025.